Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism

Naoko Takebe, Pamela Jo Harris, Yutaka Kondo, Abhilasha Nair, S. Percy Ivy, Hideyuki Saya

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer stem cells (CSC) are important to understand in order to develop solutions to treat tumor metastasis and resistance to therapy. CSCs are characterized by their ability to self-renew and differentiate into tumors, ultimately leading to therapeutic resistance. This chapter summarizes the various potential therapeutic approaches to control CSCs survival and proliferation based on preclinical and clinical study-based rationale. The proposed agents range from investigational, which are still in pre-clinical stage, already in early clinical investigational stage, or already approved for clinical use for other indications. The manuscript covers the agents targeting embryonic stem cell signaling, epigenetic control, cancer metabolism, and induction of epithelial-to-mesenchymal transition (EMT). The combination of therapeutic strategies to reduce bulk tumor populations and to target CSCs population may provide clinically meaningful tumor suppression. The development of new anti-CSC therapeutic agents and the complexity of potential molecular pathways controlling CSC survival are described in this review.

Original languageEnglish
Title of host publicationCancer Stem Cells
PublisherWiley Blackwell
Pages295-317
Number of pages23
ISBN (Print)9781118356203, 9781118356166
DOIs
Publication statusPublished - 2014 Apr 14

Fingerprint

Cell signaling
Neoplastic Stem Cells
Embryonic Stem Cells
Stem cells
Metabolism
Epigenomics
Tumors
Neoplasms
Therapeutics
Epithelial-Mesenchymal Transition
Manuscripts
Health Services Needs and Demand
Cell Survival
Neoplasm Metastasis
Population

Keywords

  • Cancer stem cells (CSCs)
  • CSC therapeutic targets
  • Embryonic stem cell signaling
  • Epigenetics
  • Epithelial-to-mesenchymal transition (EMT)
  • Hedgehog signaling pathway
  • Notch signaling pathway
  • Polycomb-repressive complexes
  • Tumor metabolism
  • Wnt signaling pathway

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Takebe, N., Harris, P. J., Kondo, Y., Nair, A., Percy Ivy, S., & Saya, H. (2014). Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism. In Cancer Stem Cells (pp. 295-317). Wiley Blackwell. https://doi.org/10.1002/9781118356203.ch23

Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism. / Takebe, Naoko; Harris, Pamela Jo; Kondo, Yutaka; Nair, Abhilasha; Percy Ivy, S.; Saya, Hideyuki.

Cancer Stem Cells. Wiley Blackwell, 2014. p. 295-317.

Research output: Chapter in Book/Report/Conference proceedingChapter

Takebe, N, Harris, PJ, Kondo, Y, Nair, A, Percy Ivy, S & Saya, H 2014, Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism. in Cancer Stem Cells. Wiley Blackwell, pp. 295-317. https://doi.org/10.1002/9781118356203.ch23
Takebe N, Harris PJ, Kondo Y, Nair A, Percy Ivy S, Saya H. Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism. In Cancer Stem Cells. Wiley Blackwell. 2014. p. 295-317 https://doi.org/10.1002/9781118356203.ch23
Takebe, Naoko ; Harris, Pamela Jo ; Kondo, Yutaka ; Nair, Abhilasha ; Percy Ivy, S. ; Saya, Hideyuki. / Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism. Cancer Stem Cells. Wiley Blackwell, 2014. pp. 295-317
@inbook{beaae3a4cdfa4f2e9c2938f404327e8b,
title = "Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism",
abstract = "Cancer stem cells (CSC) are important to understand in order to develop solutions to treat tumor metastasis and resistance to therapy. CSCs are characterized by their ability to self-renew and differentiate into tumors, ultimately leading to therapeutic resistance. This chapter summarizes the various potential therapeutic approaches to control CSCs survival and proliferation based on preclinical and clinical study-based rationale. The proposed agents range from investigational, which are still in pre-clinical stage, already in early clinical investigational stage, or already approved for clinical use for other indications. The manuscript covers the agents targeting embryonic stem cell signaling, epigenetic control, cancer metabolism, and induction of epithelial-to-mesenchymal transition (EMT). The combination of therapeutic strategies to reduce bulk tumor populations and to target CSCs population may provide clinically meaningful tumor suppression. The development of new anti-CSC therapeutic agents and the complexity of potential molecular pathways controlling CSC survival are described in this review.",
keywords = "Cancer stem cells (CSCs), CSC therapeutic targets, Embryonic stem cell signaling, Epigenetics, Epithelial-to-mesenchymal transition (EMT), Hedgehog signaling pathway, Notch signaling pathway, Polycomb-repressive complexes, Tumor metabolism, Wnt signaling pathway",
author = "Naoko Takebe and Harris, {Pamela Jo} and Yutaka Kondo and Abhilasha Nair and {Percy Ivy}, S. and Hideyuki Saya",
year = "2014",
month = "4",
day = "14",
doi = "10.1002/9781118356203.ch23",
language = "English",
isbn = "9781118356203",
pages = "295--317",
booktitle = "Cancer Stem Cells",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Targeting Cancer Stem Cells-Modulating Embryonic Stem Cell Signaling, Epigenetics, and Tumor Metabolism

AU - Takebe, Naoko

AU - Harris, Pamela Jo

AU - Kondo, Yutaka

AU - Nair, Abhilasha

AU - Percy Ivy, S.

AU - Saya, Hideyuki

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Cancer stem cells (CSC) are important to understand in order to develop solutions to treat tumor metastasis and resistance to therapy. CSCs are characterized by their ability to self-renew and differentiate into tumors, ultimately leading to therapeutic resistance. This chapter summarizes the various potential therapeutic approaches to control CSCs survival and proliferation based on preclinical and clinical study-based rationale. The proposed agents range from investigational, which are still in pre-clinical stage, already in early clinical investigational stage, or already approved for clinical use for other indications. The manuscript covers the agents targeting embryonic stem cell signaling, epigenetic control, cancer metabolism, and induction of epithelial-to-mesenchymal transition (EMT). The combination of therapeutic strategies to reduce bulk tumor populations and to target CSCs population may provide clinically meaningful tumor suppression. The development of new anti-CSC therapeutic agents and the complexity of potential molecular pathways controlling CSC survival are described in this review.

AB - Cancer stem cells (CSC) are important to understand in order to develop solutions to treat tumor metastasis and resistance to therapy. CSCs are characterized by their ability to self-renew and differentiate into tumors, ultimately leading to therapeutic resistance. This chapter summarizes the various potential therapeutic approaches to control CSCs survival and proliferation based on preclinical and clinical study-based rationale. The proposed agents range from investigational, which are still in pre-clinical stage, already in early clinical investigational stage, or already approved for clinical use for other indications. The manuscript covers the agents targeting embryonic stem cell signaling, epigenetic control, cancer metabolism, and induction of epithelial-to-mesenchymal transition (EMT). The combination of therapeutic strategies to reduce bulk tumor populations and to target CSCs population may provide clinically meaningful tumor suppression. The development of new anti-CSC therapeutic agents and the complexity of potential molecular pathways controlling CSC survival are described in this review.

KW - Cancer stem cells (CSCs)

KW - CSC therapeutic targets

KW - Embryonic stem cell signaling

KW - Epigenetics

KW - Epithelial-to-mesenchymal transition (EMT)

KW - Hedgehog signaling pathway

KW - Notch signaling pathway

KW - Polycomb-repressive complexes

KW - Tumor metabolism

KW - Wnt signaling pathway

UR - http://www.scopus.com/inward/record.url?scp=84926475250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926475250&partnerID=8YFLogxK

U2 - 10.1002/9781118356203.ch23

DO - 10.1002/9781118356203.ch23

M3 - Chapter

AN - SCOPUS:84926475250

SN - 9781118356203

SN - 9781118356166

SP - 295

EP - 317

BT - Cancer Stem Cells

PB - Wiley Blackwell

ER -